Showing results (2371-2380 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|August 19, 2003
Clinical trials update from the European Society of Cardiology Heart Failure meeting: COMET, COMPANION, Tezosentan and SHAPEAlison P Coletta, Andrew L Clark, Anne Marie L Seymour, et al.
European Journal of Heart Failure|June 12, 2003
Difficulties of introducing the National Service Framework for heart failure into general practice in the UKNigel Sparrow, David Adlam, Alan Cowley, et al.
European Journal of Heart Failure|June 12, 2003
Update of clinical trials from the American College of Cardiology 2003. EPHESUS, SPORTIF-III, ASCOT, COMPANION, UK-PACE and T-wave alternansJohn G F Cleland, Alison P Coletta, Nikolay Nikitin, et al.
European Journal of Heart Failure|January 1, 2008
The volume-sensitive chloride channel inhibitors prevent both contractile dysfunction and apoptosis induced by doxorubicin through PI3kinase, Akt and Erk 1/2Alexandra d'Anglemont de Tassigny, Alain Berdeaux, Rachid Souktani, et al.
European Journal of Heart Failure|March 18, 2008
Celecoxib modulates hypertrophic signalling and prevents load-induced cardiac dysfunctionClaudius Jacobshagen, Meike Grüber, Nils Teucher, et al.
European Journal of Heart Failure|September 25, 2007
Recall of lifestyle advice in patients recently hospitalised with heart failure: a EuroHeart Failure Survey analysisMitja Lainscak, John G F Cleland, Mattie J Lenzen, et al.
European Journal of Heart Failure|September 25, 2007
Dystrophin-deficiency increases the susceptibility to doxorubicin-induced cardiotoxicityShiwei Deng, Bettina Kulle, Mehdi Hosseini, et al.
Pageof 398